Besides, in metabolism-reprogrammed TME, decreased expressions of GLUT and HK2 impair activated TILs, and these metabolic changes correlate with increased Tregs and expression of PD-L1 and Galectin-9 on cancer cells (76). The gene discussed is HK2; the disease is cancer.